KHRNF - Khiron Life Sciences Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
2.4300
-0.0294 (-1.19%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Previous Close2.4594
Open2.3800
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.3800 - 2.4600
52 Week Range0.6637 - 3.2800
Volume114,088
Avg. Volume417,543
Market Cap225.116M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.3020
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group6 days ago

    Khiron Provides Update on Transaction to Acquire NettaGrowth

    TORONTO, May 13, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company's previously announced agreement for the acquisition (the "Acquisition") of NettaGrowth International Inc. ("NettaGrowth"), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. ("Dormul"), is progressing as planned and the Company is in the latter stages of securing local regulatory approvals in Uruguay for the completion of the Acquisition.

  • CNW Group9 days ago

    Khiron Mails and Files Circular Relating to its Annual General and Special Meeting of Shareholders

    Proxy voting deadline is May 29, 2019 at 11 a.m. (Toronto time). Board of Directors recommends that Shareholders vote FOR all resolutions. TORONTO, May 10, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, today announced it has commenced the mailing of the management information circular and other related materials (collectively, the "Meeting Materials") to Khiron's shareholders ("Shareholders") in connection with the annual general and special meeting of Shareholders (the "Meeting").

  • CNW Group13 days ago

    /C O R R E C T I O N from Source -- Khiron Life Sciences Corp./

    In the news release, Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing, issued 06-May-2019 by Khiron Life Sciences Corp. over CNW, we are advised by the company that the first paragraph, last sentence, should read "Common Share of $2.90" rather than "Common Share of $3.00" as originally issued inadvertently. TORONTO, May 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, announced today that it has entered into an agreement with Canaccord Genuity Corp. and BMO Capital Markets as co-lead underwriters and joint bookrunners, on behalf of a syndicate of underwriters (together, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, 8,621,000 common shares of the Company ("Common Shares"), on a "bought deal" basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Common Share of $2.90 (the "Issue Price") for gross proceeds of $25,000,900 (the "Offering").

  • CNW Group18 days ago

    Khiron Life Sciences Reports 2018 Fiscal Year End Results and Provides Corporate Update

    Secured approximately $40 million of investment capital for cultivation site construction, product development and distribution Became the first Colombian cannabis company to list on the TSX Venture Exchange ...

  • Khiron Gets Kuida® Into Another 150 Stores
    CNW Group20 days ago

    Khiron Gets Kuida® Into Another 150 Stores

    TORONTO, April 30, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has signed a distribution agreements for its Kuida® cosmeceutical brand with Cafam, a leading Colombian drugstore chain. This agreement further expands the brands points of sales In combination with the previous announced distribution arrangements this agreement further expands the brands retail and e-commerce points of sales in Colombia.

  • CNW Group21 days ago

    Khiron Life Sciences Signs Letter of Intent to Establish Medical Cannabis Distribution Agreement for Over 900 pharmacies in Colombia

    LOI with Copservir Ltda, Colombia's largest pharmacy chain with over 900 pharmacies across 200 cities and municipalities across the country, and sales of over CAD 500 Million per year It is anticipated ...

  • CNW Group24 days ago

    Khiron Expands to Europe, Signs Non-Binding LOI to Acquire Italy-Based Canapalife Group

    TORONTO, April 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a medical cannabis company with its core operations in Latin America, announced today that the Company has entered into a non-binding letter of agreement to acquire 100% of the outstanding securities of Canapalife S.r.l. Canapalife is a prominent hemp product company based in Italy with licenses for the cultivation, research, production and marketing of hemp-based products.

  • Dixie Brands to Host "Future of CBD & Cannabis" Lounge at New York City FounderMade Discovery Show
    CNW Group24 days ago

    Dixie Brands to Host "Future of CBD & Cannabis" Lounge at New York City FounderMade Discovery Show

    DENVER, April 25, 2019 /CNW/ - Dixie Brands (CSE: DIXI.U), (OTC: DXBRF), (Frankfurt: 0QV), one of the cannabis industry's leading consumer packaged goods ("CPG") companies, today announces a partnership with FounderMade to exclusively host the "Future of CBD & Cannabis" lounge at the FounderMade Discovery Show in New York City this coming June. Renowned for creating an environment where bold, innovative, life-changing products can thrive, the FounderMade Discovery Show is a summit for next generation companies to showcase groundbreaking products to key industry players. A pioneer in the category for the past ten years, Dixie's Future of CBD & Cannabis lounge will champion the cannabis plant and spotlight the industry as it emerges from prohibition and enters the mainstream.

  • CNW Grouplast month

    Latin American Countries Offer Unique Benefits to Cannabis Cultivators

    Predominantly, most countries which have adopted cannabis legislation have legalized the plant specifically for medical purposes. Countries such as Argentina, Chile, Colombia, and Brazil have all legalized medical cannabis, while some have also decriminalized cannabis, allowing for moderate personal consumption. In combination, all of these factors are further accelerating the Latin American cannabis industry by inviting new business opportunities.

  • CNW Grouplast month

    Khiron Appointments Larry Holifield, Former U.S. DEA Regional Director, Mexico and Central America as Khiron Security and Compliance Director, Mexico,- Joins Chief Compliance Officer Matt Murphy to Expand Company's Leadership in Compliance and Security

    Appointment of Mr. Holifield enhances Khiron's Mexico security and compliance capabilities and operational network Mr. Holifield joins a growing team for Mexico that includes country manager, Luis Chaves ...

  • CNW Grouplast month

    Tourists Find New and Destination-Worthy Attractions in Cannabis

    Additionally, a survey conducted by Colorado Tourism reported that 12 million, or approximately 15%, of those travelers participated in marijuana-related activities. Around the world, even though the cannabis industry remains in its infancy stage, more and more countries continue to legalize the plant. Thusly, the consumer base is projected to grow, propelling the overall market even further, as according to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.

  • GlobeNewswirelast month

    The Beauty of CBD: Cannabis Companies Shift Focus towards Beauty and Wellness  

    Investorideas.com, a leading investor news resource covering cannabis stocks, releases a snapshot looking at the many cannabis companies looking into the CBD beauty and wellness sector and why this sector is gaining such momentum. According to one report from the GlobalWellnessInstitute, “a wellness mindset is starting to permeate the global consumer consciousness, affecting people’s daily decision-making – whether food purchases, a focus on mental wellness and reducing stress, incorporating movement into daily life, environmental consciousness, or their yearning for connection and happiness,” noted Katherine Johnston, senior research fellow, GWI. This change in mindset combined with growing interest from large retailers, most recently CVS and Walgreens, is making many companies invest in beauty and wellness.

  • CNW Grouplast month

    Khiron Announces Partnership to Initiate the First Cannabis Clinical Research in Latin America and Expand Product Development to Address the Global Skincare Market

    TORONTO, April 10, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced that it has entered into an agreement with the prominent Colombian research hospital, Centro Dermatológico Federico Lleras Acosta ("CDFLLA"). Pursuant to the terms of the agreement, Khiron and CDFLLA will establish a clinical research partnership focused on the effectiveness of medical cannabis for dermatological conditions.

  • CNW Grouplast month

    Khiron Advances Multi-Country Operator Strategy by Signing Definitive Agreement to Acquire Licence in Uruguay

    TORONTO, April 9, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Latin America, announced today that it has signed a definitive agreement for the acquisition of NettaGrowth International Inc. ("NettaGrowth"), as previously announced on January 25, 2019. NettaGrowth will, at the time of the closing of the acquisition, own all of the outstanding shares of Dormul S.A. ("Dormul"), a Uruguayan company that has obtained the first licence to produce and export medical cannabis with THC for commercialization in Uruguay.

  • CNW Grouplast month

    Khiron Life Sciences Hires Management Team to Lead Dixie Brands Joint Venture and Continue Market Expansion Strategy in Chile and Mexico

    Seasoned capital markets leader and cannabis authority John Cooke is appointed VP of Corporate Development Luis Chavas to manage corporate development strategy and guide regulatory affairs for the Company ...

  • CNW Group2 months ago

    Khiron Life Sciences Hosts Canadian Pavilion at Cannamexico World Summit 2019, Targeting over 2,000 Global Cannabusiness Leaders

    One of the largest and most influential cannabis conferences in Latin America Two-day conference to attract over 2,000 attendees from more than ten countries First Canadian Pavilion welcomes prominent ...

  • CNW Group2 months ago

    Khiron Expands Kuida® Retail Presence, Securing Partnerships With Fedco, Colombia's Top Specialist Beauty Retailer And Linio, Latin America's Largest Online E-Retailer

    TORONTO, April 3, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that it has signed multi-channel distribution agreements for its Kuida® cosmeceutical brand with Fedco and Linio, two of the most prominent consumer distribution channels for wellness and beauty products in Colombia.  In combination with the initial product launch through Farmatodo and Farmalisto, it is anticipated that the Kuida® brand will now be made available in up to 78 retail locations and through the country's leading online portal for beauty products. Initially focused on distribution in Colombia, these agreements create potential for the Company to further expand distribution across other Latin America jurisdictions.

  • CNW Group2 months ago

    Khiron Life Sciences President Chris Naprawa to Present at BMO 2019 Cannabis Conference

    TORONTO, April 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will be presenting at the BMO 2019 Cannabis Conference, taking place April, 4th, 2019 in Toronto. Khiron President Chris Naprawa will present at 2:30pm and answer questions from conference attendees. Hosted by BMO Capital Markets, the conference is located at First Canadian Place, Toronto, 68th floor, York Room.

  • GlobeNewswire2 months ago

    CBD is Heading South; Hemp/CBD Markets Spreading into Mexico and South America

    In November 2018, Mexico announced approval for the importation and sale of cannabis products at pharmacies and retailers across the country to service the Mexican population of 130+ million.  Sixty product licenses have been initially approved by the COFEPRIS thus far, and it is expected this decision will make cannabis products like hemp-derived CBD available on the shelves of general retailers across the nation. CannaOne Technologies (CSE: CNNA), a company that develops and markets various digital tools to service various segments for the cannabis industry in Canada, with its flagship product BloomKit, is taking advantage of this new southern market potential.

  • CNW Group2 months ago

    Khiron VP of Compliance Matt Murphy to Represent Company on U.S. National Cannabis Roundtable With John Boehner, Former Speaker of the U.S. House of Representatives

    TORONTO, March 28, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today its participation, through Matt Murphy's appointment, in the newly formed National Cannabis Roundtable ("NCR"), a campaign aimed at reforming US federal cannabis laws. The NCR will focus on advocating for a rational legal framework for cannabis reform in the US with former Speaker of the House, John Boehner, serving as Honorary Chairman.

  • GlobeNewswire2 months ago

    Vertically Integrated Cannabis Companies on Tour: A New Era of Confidence as Regulations Change

    POINT ROBERTS, Wash. and DELTA, British Columbia, March 22, 2019 -- Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot.

  • CNW Group2 months ago

    Why Analysts are Projecting $75 Billion Cannabis Market by 2030

    PALM BEACH, Florida , March 14, 2019 /CNW/ -- Recently, retail and online cannabis has had good news and bad news. The good news is that sales numbers continue to increase and projected revenues keep trending ...

  • Dixie Brands and Khiron Life Sciences to bring more than 100 market-proven products to the Latin American cannabis market
    CNW Group2 months ago

    Dixie Brands and Khiron Life Sciences to bring more than 100 market-proven products to the Latin American cannabis market

    DENVER and TORONTO, March 14, 2019 /CNW/ - Dixie Brands Inc. ("Dixie") (CSE:DIXI.U), (Frankfurt: 0QV), (OTC:DXBRF - News),  one of the cannabis industry's leading consumer packaged goods ("CPG") companies, and Khiron Life Sciences Corp. ("Khiron") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, have signed a definitive agreement (the "Agreement") relating to the joint venture (the "JV") the companies announced on January 30, 2019. With the execution of the Agreement, a new company called Dixie Khiron JV Corp. ("Dixie-Khiron") has been established, 50% owned by each of Dixie and Khiron.

  • CNW Group2 months ago

    Khiron Life Sciences Expands Skincare Leadership Team With The Appointment Of Dr. Edwin Bendek as Medical Director, Skincare

    Appointment further strengthens commercial skincare business where Company was first to launch products into Colombia market in 2018 Skincare unit targets $10 Billion Latin America skincare market Dr. ...

  • CNW Group2 months ago

    Khiron Life Sciences President Chris Naprawa To Present at 2019 LD Micro Virtual Conference

    TORONTO, March 12, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will be presenting at the second annual LD Micro Virtual Conference on March 13th at 12:20pm EDT. Khiron president Chris Naprawa will present and answer questions from participating investors.